Hatteras Venture Partners — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
HealthtechHenrico, US
Will Saunders(Executive Officer, Director)Robert Schultz(Director)Mark Tripodi(Executive Officer)Tania Grant(Director)John Mark Ramsey(Director)
Board seatLauren Pierce Flickinger· per SEC Form D · $5.6M raise · filed Aug 2026
Co-investorsZiegler Link-age Funds
Ladder operates a marketplace that connects construction employers with skilled trade workers for hiring and staffing needs.
Construction TechMarketplacesPropTechAtlanta, US
Co-investorsY CombinatorCREATE HEALTH VENTURESGROOVE CAPITALJumpstart CapitalNina Capital
CREATE Medicines develops in vivo CAR immunotherapy using proprietary mRNA-LNP technology to program T cells, NK cells, and myeloid cells directly within the body for cancer, autoimmunity, and fibrosis.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsARCH Venture Partners8VCNewpath Partners
Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid.
BiotechDeep TechHealthtechMedical Devices
Mark Wagner(Founder, Investor, & Director)inAmaza Reitmeier(CEO)
Co-investorsArboretum VenturesIAG Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.